Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Blocking the mineralocorticoid receptor can help treat skin thinning caused by steroids.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

New compounds with carborane showed anti-androgen effects similar to flutamide.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Rats developed lung issues from the drugs, but these cleared quickly after stopping them.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.